![](/img/cover-not-exists.png)
EBV+ CNS LYMPHOMAS HAVE A DISTINCTIVE TUMOR MICROENVIRONMENT AND GENETIC PROFILE, WHICH IS AMENABLE TO COMBINATION 3 RD PARTY EBV-SPECIFIC CTL AND IBRUTINIB THERAPY
Gandhi, M.K., Hoang, T., Tobin, J.W., Law, S.C., Talaulikar, D., Jain, S., Vari, F., Murigneux, V., Fink, L., Gunawardana, J., Gould, C., Oey, H., Delecluse, S., Trappe, R.U., Merida de Long, L., SabdVolume:
37
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.91_2629
Date:
June, 2019
File:
PDF, 359 KB
english, 2019